A growing need for patients to take a more proactive role in their health has led to recent trends in "patient-centric medicine" and "telehealth." Healthcare providers who need to monitor patients on a frequent basis, or clinical trial managers who want to recruit participants in remote locations can now use tools and technologies that allow them to conduct virtual check-ins with trial recruits or patients. At-home blood collection with patient-friendly kits is a helpful tool for "going virtual" with patient monitoring and care.
At the beginning of April 2020, it was reported by Johns Hopkins University that the number of COVID-19 infections had surpassed the 1 million mark globally, and the number of cases was still rising. In the face of the devastating Coronavirus pandemic that is causing the COVID-19 infections, the race is on to find effective treatments as well as an effective vaccine.
Clinical trial monitoring is an essential process of drug development. It is the stage where developed drugs are tested on human subjects to determine if they are effective.
Fear over the recent coronavirus outbreak continues to manifest in extreme ways. Retail stores have run out of hand sanitizers; the stock market has plunged, and healthcare institutions are overwhelmed.